| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $73K | -48.2% | -54.9% |
| SG&A Expense | $178K | +2.3% | +13.4% |
| Operating Income | -$251K | +20.3% | +21.3% |
| Net Income | -$255K | +20.8% | +21.8% |
| EPS (Basic) | $0.01 | -50.0% | +0.0% |
| EPS (Diluted) | $0.01 | -50.0% | +0.0% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Current Assets | $5K | -82.1% | -89.8% |
| Total Assets | $7K | -76.7% | -86.3% |
| Current Liabilities | $1.3M | +17.9% | +90.6% |
| Stockholders' Equity | -$1.3M | -20.6% | -105.2% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$256K | — | — |
| Financing Cash Flow | $240K | — | — |